Novo Nordisk Initiates Lawsuit Against Eli Lilly Alleging Deceptive Advertising in Blockbuster Weight Loss and Diabetes Drug Market
In a significant escalation of the fiercely competitive market for GLP-1 agonist drugs, Danish pharmaceutical giant Novo Nordisk has filed a lawsuit against its American rival, Eli Lilly, alleging that…
